Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Assets Average (2020 - 2025)

Historic Assets Average for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $478.9 million.

  • GeneDx Holdings' Assets Average rose 2002.97% to $478.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $478.9 million, marking a year-over-year increase of 2002.97%. This contributed to the annual value of $419.1 million for FY2024, which is 786.66% down from last year.
  • Latest data reveals that GeneDx Holdings reported Assets Average of $478.9 million as of Q3 2025, which was up 2002.97% from $455.1 million recorded in Q2 2025.
  • GeneDx Holdings' Assets Average's 5-year high stood at $881.1 million during Q3 2022, with a 5-year trough of $197.4 million in Q2 2021.
  • In the last 5 years, GeneDx Holdings' Assets Average had a median value of $446.8 million in 2023 and averaged $477.7 million.
  • As far as peak fluctuations go, GeneDx Holdings' Assets Average skyrocketed by 26748.73% in 2022, and later crashed by 4928.8% in 2023.
  • Over the past 5 years, GeneDx Holdings' Assets Average (Quarter) stood at $578.7 million in 2021, then increased by 14.04% to $660.0 million in 2022, then tumbled by 36.66% to $418.0 million in 2023, then decreased by 0.94% to $414.1 million in 2024, then grew by 15.64% to $478.9 million in 2025.
  • Its Assets Average stands at $478.9 million for Q3 2025, versus $455.1 million for Q2 2025 and $432.9 million for Q1 2025.